Rhelion Life Sciences Corp. (4YX0)
FSX
0.00200
-0.0069 (-77.53%)
Real-time Data
06:00 AM
Day's Range
0.002000.00200
52 wk Range
0.000500.0249
Financial Statements - 4YX0 - Rhelion Life Sciences Corp.
Revenue
4.19M
Net Income
-6.84MNet Margin -163.2%
EBITDA
-3.50M
Free Cash Flow
-3.64M
Income Statement
| Period Ending | 2026-03-31 |
|---|---|
| Sales | 4.19M |
| Cost of Goods | 2.60M |
| Gross Profit | 1.59M |
 Operating Expense | - |
| Operating Income | -4.12M |
| Non-Operating Interest | - |
| Other Income Expense | -3.24M |
| Pre Tax Income | -7.17M |
| Income Tax | -325.70K |
| Net Income | -6.84M |
| EPS Basic | -0.014647 |
| EPS Diluted | -0.014647 |
| Basic Shares Outstanding | 416.59M |
| Diluted Shares Outstanding | 416.59M |
| Ebit | -7.11M |
| Ebitda | -3.50M |
| Net Income Continuous Operations | -6.84M |
| Minority Interests | 742.96K |
| Preferred Stock Dividends | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
